DigestRedComo funciona
Red
/
Empresas
No
No verificado

Nocion Therapeutics, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

6 Comunicados de prensa

Ver todos los comunicados de prensa
26/01/2026
Asociaciones/Profesionales
Salud
Medicina - Varios
Farmacéutica
Biotecnología
Industria
Eventos
Nocion Therapeutics to Present Preclinical Data Supporting Nocions™ as a Novel Approach for the Treatment of Pain at the Non-Opioid Pain Therapeutics Summit
Fuente
Nocion Therapeutics, Inc.
Editor
Business Wire
1.00
0
07/01/2026
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Nocion Therapeutics Extends Series B Financing to $93 Million to Support Late-Stage Development of Taplucainium in Chronic Cough
Fuente
Nocion Therapeutics, Inc.
Editor
Business Wire
1.00
0
28/04/2025
Mercado laboral
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Nocion Therapeutics Appoints Matthew Frankel, M.D., MBA to Chief Medical Officer
Fuente
Nocion Therapeutics, Inc.
Editor
Business Wire
1.00
0
18/11/2024
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Industria
Nocion Therapeutics Announces First Patient Dosed in ASPIRE Phase 2b Chronic Cough Study
Fuente
Nocion Therapeutics, Inc.
Editor
Business Wire
1.00
0
15/07/2024
Eventos
Industria
Salud
Sanidad
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Nocion Therapeutics Presents Data on Preclinical and Clinical Development of Taplucainium, a Novel, Charged Sodium Channel Blocker, as a potential treatment for Chronic Cough at the 13th London International Cough Symposium
Fuente
Nocion Therapeutics, Inc.
Editor
Business Wire
1.00
0
08/07/2024
Mercado laboral
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Nocion Therapeutics Appoints Dr. Catherine Bonuccelli to Scientific Advisory Board and Joan Shaw to Senior Vice President, Clinical Operations
Fuente
Nocion Therapeutics, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0